Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs

This publication has 62 references indexed in Scilit:

• Antisense oligonucleotides: towards clinical trials
  Trends in Biotechnology, 1996
• Guanine-rich oligonucleotide modified at the 5′ terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein
  Antiviral Research, 1996
• Antisense Oligonucleotides
  Accounts of Chemical Research, 1995
• Thrombolysis and Reocclusion in Experimental Jugular Vein and Coronary Artery Thrombosis
  Circulation, 1995
• Inhibition by Modified Oligodeoxynucleotides of the Expression of Type‐1 Plasminogen Activator Inhibitor in Human Endothelial Cells
  European Journal of Biochemistry, 1995
• Modified oligonucleotides in rabbit reticulocytes: uptake, stability and antisense properties
  Biochimie, 1991
• Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells
  Blood, 1989
• Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay
  Blood, 1988
• Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.
  Molecular and Cellular Biology, 1987